Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

CVD screening in low-risk, asymptomatic adults: clinical trials needed.

Polonsky TS, Greenland P.

Nat Rev Cardiol. 2012 Oct;9(10):599-604. doi: 10.1038/nrcardio.2012.114. Epub 2012 Aug 14.

PMID:
22889949
2.
3.
4.

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.

6.

The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: systematic review.

Waugh N, Black C, Walker S, McIntyre L, Cummins E, Hillis G.

Health Technol Assess. 2006 Oct;10(39):iii-iv, ix-x, 1-41. Review.

7.

Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.

Mangili A, Gerrior J, Tang AM, O'Leary DH, Polak JK, Schaefer EJ, Gorbach SL, Wanke CA.

Clin Infect Dis. 2006 Dec 1;43(11):1482-9. Epub 2006 Oct 31.

8.

Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study.

Cao JJ, Arnold AM, Manolio TA, Polak JF, Psaty BM, Hirsch CH, Kuller LH, Cushman M.

Circulation. 2007 Jul 3;116(1):32-8. Epub 2007 Jun 18.

9.

Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?

Fabbri G, Maggioni AP.

Adv Ther. 2009 May;26(5):469-87. doi: 10.1007/s12325-009-0025-6. Epub 2009 May 14. Review.

PMID:
19444394
10.

From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.

Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvi TZ, Shaw LJ, Faergeman O, Cohn J, Bahr R, Koenig W, Demirovic J, Arking D, Herrera VL, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK; SHAPE Task Force.

Am J Cardiol. 2006 Jul 17;98(2A):2H-15H. Epub 2006 Jun 12. Review.

PMID:
16843744
11.

Expert review on coronary calcium.

Budoff MJ, Gul KM.

Vasc Health Risk Manag. 2008;4(2):315-24. Review.

12.

The first SHAPE (Screening for Heart Attack Prevention and Education) guideline.

Naghavi M, Falk E, Hecht HS, Shah PK; SHAPE Task Force.

Crit Pathw Cardiol. 2006 Dec;5(4):187-90. doi: 10.1097/01.hpc.0000249784.29151.54.

PMID:
18340236
13.

High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?

Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, Blumenthal RS, Budoff MJ.

J Am Coll Cardiol. 2013 Jul 30;62(5):397-408. doi: 10.1016/j.jacc.2013.05.016. Epub 2013 May 30. Review.

14.

Screening strategies for cardiovascular disease in asymptomatic adults.

Wallace ML, Ricco JA, Barrett B.

Prim Care. 2014 Jun;41(2):371-97. doi: 10.1016/j.pop.2014.02.010. Epub 2014 Mar 27. Review.

15.

Screening for type 2 diabetes: literature review and economic modelling.

Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A.

Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi, 1-125. Review.

16.

Intensive statin therapy for Indians: Part-I. Benefits.

Enas EA, Pazhoor HC, Kuruvila A, Vijayaraghavan K.

Indian Heart J. 2011 May-Jun;63(3):211-27. Review.

PMID:
22734339
17.

Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events.

Schnell-Inderst P, Schwarzer R, Göhler A, Grandi N, Grabein K, Stollenwerk B, Klauß V, Wasem J, Siebert U.

GMS Health Technol Assess. 2009 May 12;5:Doc06. doi: 10.3205/hta000068.

18.

The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines.

Mora S, Musunuru K, Blumenthal RS.

Clin Chem. 2009 Feb;55(2):219-28. doi: 10.1373/clinchem.2008.109728. Epub 2008 Dec 18. Review.

19.

Association of inflammatory markers and carotid intima-media thickness with the risk of cardiovascular events in high-risk patients.

Okazaki S, Furukado S, Abe Y, Tanaka M, Miwa K, Yamagami H, Sakaguchi M, Sakoda S, Kitagawa K.

Cerebrovasc Dis. 2010;30(2):180-7. doi: 10.1159/000317106. Epub 2010 Jun 29.

PMID:
20588013
20.

The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force.

Lin JS, Olson CM, Johnson ES, Whitlock EP.

Ann Intern Med. 2013 Sep 3;159(5):333-41. doi: 10.7326/0003-4819-159-5-201309030-00007. Review.

PMID:
24026319
Items per page

Supplemental Content

Write to the Help Desk